Treatment of patients with newly diagnosed medulloblastoma, supratentorial primitive neuroectodermal tumor, or atypical teratoid rhabdoid tumor.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Cyclophosphamide; Filgrastim; Vincristine
- Indications CNS cancer; Medulloblastoma; Neuroblastoma; Primitive neuroectodermal tumours; Rhabdoid tumour
- Focus Pharmacogenomic; Therapeutic Use
- 21 Dec 2020 Biomarkers information updated
- 18 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 24 Jul 2012 Planned number of patients changed from 410 to 413 as reported by ClinicalTrials.gov.